Peripheral Neuropathy Trial, Recruiting NCT06765551 Sponsor: Jena University Hospital Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT06765551
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People scheduled for a major planned (non-emergency) surgery, such as heart, chest, or abdominal surgery
  • People expected to stay in the intensive care unit (ICU) for more than one day after their surgery
  • Healthy people of a similar age who do not have ICU-acquired muscle weakness, recruited from staff at the relevant hospital department (to serve as a comparison group)

Who may not be able to join:

  • People who have not given their informed consent to participate
  • People requiring emergency surgery
  • People who have previously taken part in this same study
  • People with a pre-existing disease affecting the muscles or nerves
  • People with a pre-existing brain or nervous system condition that has caused lasting muscle or movement problems (for example, a previous stroke, brain bleed, or brain tumour)
  • People who are receiving or have received very high doses of steroid medication (such as more than 300 mg of hydrocortisone or an equivalent dose of a similar drug, per day) before or during the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: PD Dr. Johannes Ehler, M.D., Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital

Phone: +4936419323397

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jena University Hospital
Registry
ClinicalTrials.gov
Start date
1 October 2024
Est. completion
31 December 2025

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Incidence of abnormalities of muscle echogenicity assesed by muscular ultrasound

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov